Akums Drugs and Pharmaceuticals to host investor meet on June 8

0 min read     Updated on 04 Jun 2026, 12:40 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Akums Drugs and Pharmaceuticals Limited has announced an India Investor Conference scheduled for June 8, 2026, at 09:00 AM IST. The physical group meet will be held at the Grand Hyatt in Mumbai to discuss performance and strategy.

powered bylight_fuzz_icon
42038575

*this image is generated using AI for illustrative purposes only.

Akums Drugs and Pharmaceuticals Limited has scheduled an India Investor Conference to engage with shareholders and market analysts. The meeting is set to take place on June 8, 2026, providing a platform for the company to discuss its performance and strategy.

The session will be conducted as a physical group meet starting at 09:00 AM IST. The venue for the conference is the Grand Hyatt in Mumbai.

Meeting Details

Particulars Details
Type of Meet Physical Conference Call – India Investor Conference
Date June 8, 2026
Time 09:00 AM (IST)
Location Grand Hyatt, Mumbai / Physical

A copy of this disclosure has been updated on the official website of Akums Drugs and Pharmaceuticals Limited at www.akums.in .

Historical Stock Returns for Akums Drugs & Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%+3.47%-0.96%+31.76%-0.05%-30.45%

What strategic initiatives will Akums highlight to drive future growth?

How will the company address potential market challenges in the pharmaceutical sector?

What are the expected financial targets for the upcoming fiscal year?

Akums Drugs and Pharmaceuticals to host investor meet on June 1

1 min read     Updated on 29 May 2026, 03:52 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Akums Drugs and Pharmaceuticals has scheduled a physical investor and analysts conference call for June 1, 2026, at the Grand Hyatt in Mumbai. The event, themed 'Rising Stars', is a group meet where no unpublished price sensitive information will be shared. The late intimation was attributed to the decision process taking longer than anticipated.

powered bylight_fuzz_icon
41531297

*this image is generated using AI for illustrative purposes only.

Akums Drugs and Pharmaceuticals has announced it will conduct a physical investor and analysts conference call on June 1, 2026. The meeting, designated as a group meet under the theme 'Rising Stars', is scheduled to begin at 09:00 AM IST at the Grand Hyatt in Mumbai. The intimation was submitted to the exchanges pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company stated that the decision process for the event took more time than anticipated, resulting in the late intimation regarding the schedule. Akums clarified that no unpublished price sensitive information pertaining to the company will be shared during the meet with analysts and investors. The schedule remains subject to change due to exigencies on the part of the host or the company.

Meeting Details

The following table outlines the specific particulars of the scheduled conference call:

S. No. Particulars of Meet Date of Meeting Type of Meet Location / Mode of Meeting Reason for late intimation
1. Physical Conference Call- "Rising Stars" 1st June, 2026
Starts at 09:00 AM (IST)
Group meet Grand Hyatt, Mumbai/ Physical Decision process took more time than anticipated

Dharamvir Malik, Company Secretary & Compliance Officer, signed the disclosure on behalf of Akums Drugs and Pharmaceuticals Limited. A copy of the disclosure has been updated on the company's official website.

Historical Stock Returns for Akums Drugs & Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%+3.47%-0.96%+31.76%-0.05%-30.45%

What specific growth drivers or strategic initiatives will Akums highlight under the 'Rising Stars' theme?

How might the 'Rising Stars' group meet influence investor sentiment and stock performance ahead of the event?

Could the late intimation signal underlying operational challenges or strategic shifts within the company?

More News on Akums Drugs & Pharma

1 Year Returns:-0.05%